Variants in the MIPEP gene presenting with complex neurological phenotype without cardiomyopathy, impair OXPHOS protein maturation and lead to a reduced OXPHOS abundance in patient cells
| Autor: | Agnès Rötig, Arnold Munnich, Metodi D. Metodiev, Juliette Pulman, Martin Horak, Giulia Barcia, Nathalie Boddaert, Benedetta Ruzzenente |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Mitochondrial Diseases Ataxia Endocrinology Diabetes and Metabolism Mitochondrial disease Cardiomyopathy Gene Expression Mitochondrion Compound heterozygosity Biochemistry Young Adult Endocrinology Genetics medicine Humans Molecular Biology Protein maturation Alleles biology Metalloendopeptidases Fibroblasts medicine.disease Hypotonia Cell biology HEK293 Cells Phenotype Mutation biology.gene medicine.symptom Cardiomyopathies Mitochondrial intermediate peptidase |
| Zdroj: | Molecular Genetics and Metabolism. 134:267-273 |
| ISSN: | 1096-7192 |
| Popis: | Most mitochondrial proteins are synthesized in the cytosol and targeted to mitochondria via N-terminal mitochondrial targeting signals (MTS) that are proteolytically removed upon import. Sometimes, MTS removal is followed by a cleavage of an octapeptide by the mitochondrial intermediate peptidase (MIP), encoded by the MIPEP gene. Previously, MIPEP variants were linked to four cases of multisystemic disorder presenting with cardiomyopathy, developmental delay, hypotonia and infantile lethality. We report here a patient carrying compound heterozygous MIPEP variants—one was not previously linked to mitochondrial disease—who did not have cardiomyopathy and who is alive at the age of 20 years. This patient had developmental delay, global hypotonia, mild optic neuropathy and mild ataxia. Functional characterization of patient fibroblasts and HEK293FT cells carrying MIPEP hypomorphic alleles demonstrated that deficient MIP activity was linked to impaired post-import processing of subunits from four of the five OXPHOS complexes and decreased abundance and activity of some of these complexes in human cells possibly underlying the development of mitochondrial disease. Thus, our work expands the genetic and clinical spectrum of MIPEP-linked disease and establishes MIP as an important regulator of OXPHOS biogenesis and function in human cells. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect